COMPARE · Data as of August 21, 2026
PACS vs THC
Verdict: Side-by-side breakdown using the Bull Rankings model. PACS scored 70.7, THC scored 49.5 — PACS leads.
Compare another set
PACS
PACS Group, Inc.
70.7
$44.25 · $7.0B
fundamentals as of
Score gap
21.2
PACS leads
THC
Tenet Healthcare Corporation
49.5
$280.77 · $22.6B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestTHC10.9x
- Fastest growthPACS+15.2%
- Strongest balance sheetTHC1.52
- Highest qualityTHC84 / 100
- Largest discount to fair valueTHC-33%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
PACS
stronger →← stronger
THC
63
Qualityreturns · margins · balance sheet
84
90
Growthrevenue & earnings expansion
35
63
Valuevaluation vs sector peers
42
PACS is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
PACS
THC
$121mC
FCF
$3.0bB
+15.2%B+
Rev
+5.4%C+
3.05D
D/E
1.52C
25.9xB
P/E
10.9xA
1.19B+
PEG
1.96C+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
PACS
THC
252% above
Price vs fair valuelower is cheaper
33% below
~38%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-9%/yr
-73%
1-yr DCF upside
+59%
-72%
5-yr DCF upside
+50%
-69%
10-yr DCF upside
+38%
These two disagree on this pair: the Value pillar ranks cheapness against sector peers, while price-vs-fair-value is an absolute read. A name can be the better value in its sector and still the dearer one on cash flows.
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
PACS
Why this score
- Short track record
THC
Why this score
- Buying back stock
- Durable high returns
The companies
PACSPACS Group, Inc.
Why now
Medical Care Facilities · market cap $7.0b. 11% off the 52-week high of $49.49. Revenue growing +15%, comfortably above the S&P median. 5 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $59.20 (implying +34% upside).
Moat
ROE 24% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
D/E 3.05 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Net margin 4.9% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
THCTenet Healthcare Corporation
Why now
Medical Care Facilities · market cap $22.6b. Trading near 52-week high of $280.89 — momentum setup, limited technical margin of safety. 21 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $282.48 (implying +1% upside).
Moat
Net margin 15% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 68% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 95% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trading within 0% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where PACS and THC diverge
On the headline score the gap is 21.2 points in favor of PACS. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
- GrowthPACS 89.7 · THC 34.7PACS +55.0
- QualityPACS 62.8 · THC 84.1THC +21.3
- ValuePACS 62.7 · THC 41.7PACS +21.0
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.